Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung Cancer.

Hirotsugu Kenmotsu,Nobuyuki Yamamoto,Takeharu Yamanaka,Katsuo Yoshiya,Toshiaki Takahashi,Tsuyoshi Ueno,Koichi Goto,Haruko Daga,Norihiko Ikeda,Kenji Sugio,Takashi Seto,Shinichi Toyooka,Hiroshi Date,Tetsuya Mitsudomi,Isamu Okamoto,Kohei Yokoi,Hideo Saka,Hiroaki Okamoto,Yuichi Takiguchi,Masahiro Tsuboi

Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung Cancer.

2020

PURPOSETo evaluate the efficacy of pemetrexed plus cisplatin versus vinorelbine plus cisplatin as postoperative adjuvant chemotherapy in patients with pathologic stage II-IIIA nonsquamous non–small...

Keywords:

Oncology
Cisplatin
non small cell
Internal medicine
in patient
adjuvant chemotherapy
Pemetrexed
stage ii
Vinorelbine
Lung cancer
Pathology
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations